- publications/archive November 4, 2010 PEN 19 - Voluntary Initiatives, Regulation, and Nanotechnology Oversight Enough voluntary initiatives for nanotechnology have been implemented so they can be looked at together, in a comparative sense, and historically, in terms of their relationship to programs that have preceded them. This report provides that analysis for the first time.
- publications/archive August 25, 2009 Nanotechnology and Consumer Products
- publications/archive April 28, 2009 PEN 18 - Oversight of Next Generation Nanotechnology Existing health and safety agencies are unable to cope with the risk assessment, standard setting and oversight challenges of advancing nanotechnology.
- publications/archive April 6, 2009 Toward a Comprehensive Strategy for Nanotechnology Risk Communication The last in a trio of studies: Cultural Cognition and Nanotechnology Risk Perceptions: An Experimental Investigation of Message Framing, asks what science will reveal about the risks and benefits of nanotechnology and what conclusions members of the public will form? It takes an in depth look at the power of information framing to accentuate or mitigate cultural polarization.
- publications/archive January 27, 2009 PEN 16 - Nanotechnology: The Social and Ethical Issues “It is crucial to address social and ethical issues now as we consider both the substantial potential risks of nanotechnology and its possible significant contributions to our well-being and environmental sustainability,” says report author Ronald Sandler. PEN 16 emphasizes ways in which these issues intersect with governmental functions and responsibilities, including science and technology policy, as well as research funding, regulation and work on public engagement.
- publications/archive January 14, 2009 PEN 17 - A Hard Pill to Swallow Historically, the regulation of dietary supplements has been a significant challenge for the U.S. Food and Drug Administration (FDA), and the fact that some of these products are now being manufactured using nanotechnology creates an additional layer of complexity. Is FDA equipped to meet the emerging regulatory challenge of dietary supplements that use engineered nanomaterials?
- publications/archive December 9, 2008 Federal Government Nanotechnology Environment, Health and Safety Research Federal risk-research funding options for moving forward under the next administration
- publications/archive August 21, 2008 PEN 14 - The Consumer Products Safety Commission and Nanotechnology The inability of the Consumer Product Safety Commission (CPSC) to carry out its mandate with respect to simple, low-tech products such as children’s jewelry and toy trains bodes poorly for its ability to oversee the safety of complex, high-tech products made using nanotechnology, according to E. Marla Felcher.
- publications/archive July 23, 2008 PEN 13 - Nanotechnology Oversight Few domestic policy areas that the new administration must address will have greater long-range consequences than nanotechnology — a new technology that has been compared with the industrial revolution in terms of its impact on society. If the right decisions are made, nanotechnology will bring vast improvements to almost every area of daily living. If the wrong decisions are made, the American economy, human health and the environment will suffer.
- publications/archive June 25, 2008 Assuring the Safety of Nanomaterials in Food Packaging Engineered nanoscale materials (ENMs), which contain novel properties that offer potential benefits for use in food packaging, raise new safety evaluation challenges for regulators and industry. The report examines the path of a number of hypothetical nanotechnology food packaging applications through the current regulatory system.
- publications/archive April 24, 2008 Congressional Testimony - National Nanotechnology Initiative: Charting the Course for Reauthorization New nanotechnology consumer products are coming on the market at the rate of three to four per week, a finding based on the latest update to the nanotechnology consumer product inventory. Today, in testimony before the U.S. Senate Committee on Commerce, Science & Transportation, PEN Project Director David Rejeski cited Ace Silver Plus—another of the nine nano toothpastes in the inventory—as an example of the upsurge in nanotechnology consumer products in stores. The hearing marks the start of U.S. Senate debate on the future direction of the annual $1.5 billion federal investment in nanotechnology research and development .
- publications/archive April 16, 2008 House Science and Technology Committee’s hearing on the National Nanotechnology Initiative Amendments Act of 2008 Today at the House Science and Technology Committee’s hearing on the National Nanotechnology Initiative Amendments Act of 2008, testimony highlighted shortfalls in the current U.S. Government Strategy. According to Dr. Andrew Maynard, without clear leadership and more transparency in federal risk research investment, the emergence of safe nanotechnologies will be a happy accident, rather than a foregone conclusion.
- publications/archive April 9, 2008 PEN 11 - Room at the Bottom? State and local governments often have adopted trailblazing initiatives to address environmental, health and safety concerns in advance or in lieu of federal action. With nanotechnology, an emerging field of science with unknown risks, this practice is continuing, a landmark study has found.
- publications/archive February 28, 2008 First Annual Conference on Nanotechnology Law, Regulation and Policy Keynote address from Michael R. Taylor at the First Annual Conference on Nanotechnology Law, Regulation and Policy.
- publications/archive February 26, 2008 Application of the Toxics Release Inventory to Nanomaterials This research brief examines whether the legal authorities that establish the Toxics Release Inventory (TRI) in the Emergency Planning and Community-Right to-Know Act (EPCRA) could be applied to nanomaterials. Although several organizations have published analyses of whether specific environmental laws could be used to regulate nanomaterials, none of these reviews has examined EPCRA or TRI in any detail.